Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
2526
DELISTED
LHC Group LLC
LHCG
| $1.25M | ﹤0.01% |
9,069
-13,600
| -60% | -$1.69M |
|
2527
Hennessy Advisors
HNNA
$78.6M
| $1.25M | ﹤0.01% |
123,725
+14,201
| +13% | +$158K |
|
|
PACD
2528
DELISTED
Pacific Drilling S.A. Common Shares
PACD
| $1.24M | ﹤0.01% |
304,900
+49,200
| +19% | +$154K |
|
2529
Hallador Energy
HNRG
$758M
| $1.24M | ﹤0.01% |
416,058
-72,400
| -15% | -$222K |
|
|
SUP
2530
DELISTED
Superior Industries International
SUP
| $1.24M | ﹤0.01% |
+334,959
| New | +$1.02M |
|
2531
Movado Group
MOV
$798M
| $1.23M | ﹤0.01% |
56,536
-226,300
| -80% | -$5.29M |
|
2532
BGSF Inc
BGSF
$60.7M
| $1.23M | ﹤0.01% |
56,000
+18,300
| +49% | +$373K |
|
2533
Unity Bancorp
UNTY
$617M
| $1.23M | ﹤0.01% |
54,301
+10,401
| +24% | +$230K |
|
2534
iShares Russell 3000 ETF
IWV
$20.5B
| $1.23M | ﹤0.01% |
+6,500
| New | +$1.17M |
|
2535
Broadwind
BWEN
$124M
| $1.22M | ﹤0.01% |
737,200
| – | – |
|
|
GDP
2536
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $1.22M | ﹤0.01% |
121,900
+500
| +0.4% | +$4.86K |
|
|
EMMS
2537
DELISTED
Emmis Communications Corp
EMMS
| $1.22M | ﹤0.01% |
323,221
+24,536
| +8% | +$105K |
|
2538
Babcock & Wilcox
BW
$1.56B
| $1.22M | ﹤0.01% |
333,950
+68,770
| +26% | +$269K |
|
2539
Beasley Broadcasting Group
BBGI
$42M
| $1.21M | ﹤0.01% |
19,596
+2,686
| +16% | +$158K |
|
|
SHLO
2540
DELISTED
Shiloh Industries Inc
SHLO
| $1.21M | ﹤0.01% |
339,811
+48,300
| +17% | +$186K |
|
2541
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
| $1.21M | ﹤0.01% |
+104,000
| New | +$1.15M |
|
|
INFI
2542
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.21M | ﹤0.01% |
1,258,313
+137,373
| +12% | +$151K |
|
2543
Heritage Financial
HFWA
$1.22B
| $1.2M | ﹤0.01% |
42,499
-26,090
| -38% | -$720K |
|
2544
Qfin Holdings
QFIN
$1.5B
| $1.2M | ﹤0.01% |
+122,700
| New | +$1.11M |
|
|
ICBK
2545
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $1.2M | ﹤0.01% |
46,671
-3,442
| -7% | -$79.8K |
|
2546
NI Holdings
NODK
$314M
| $1.2M | ﹤0.01% |
69,501
-5,100
| -7% | -$87.4K |
|
|
ELGX
2547
DELISTED
Endologix Inc
ELGX
| $1.19M | ﹤0.01% |
755,668
+44,400
| +6% | +$124K |
|
2548
KraneShares CSI China Internet ETF
KWEB
$5.33B
| $1.19M | ﹤0.01% |
+24,500
| New | +$1.12M |
|
|
CMLS
2549
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $1.19M | ﹤0.01% |
67,804
+54,016
| +392% | +$827K |
|
|
AKCA
2550
DELISTED
Akcea Therapeutics Inc
AKCA
| $1.19M | ﹤0.01% |
+70,200
| New | +$1.31M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.